\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationOnline
ProgrammesNTNU, the Norwegian University of Science and Technology, organises within its webinar series "One hour with Europe" a webinar during which the Director of the EU AI Office within the European Commission, Lucilla Sioli will provide information on "The AI Act and the Future of European Digital Competitiveness".
Registration to the webinar is possible until 3 October 12.00 CET via this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Culture and society Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
